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Purpose: This retrospective review describes the surgical management and clinical outcome for renal artery aneurysms
(RAAs) in 62 consecutive patients.
Methods: From January 1987 through July 2003, 804 patients had operative renal artery (RA) repair involving 1206
kidneys at our center. A subgroup of 62 patients (42 women, 20 men; mean age 46  18 years) received repair of 72
RAAs. Demographic data, comorbidity, and surgical technique were examined. Blood pressure and renal function
response were determined. Patency of repair was evaluated by renal duplex sonography. Primary patency and patient
survival were estimated by life-table methods. Tests of association were performed using 2 and the Student t tests.
Results: Seventy-two RAs were repaired for RAA with a mean diameter of 2.6 cm (range, 1.3 to 5.5 cm). Bilateral RAAs
were present in 21 patients. Associated conditions included fibromuscular dysplasia, atherosclerosis, and arteritis in 54%,
35%, and 7%, respectively. Hypertension was present in 89% (mean blood pressure, 171  35/95  19 mm Hg; mean
medications, 2.2 1.2 drugs) and renal insufficiency was present in 8% (mean serum creatinine, 1.9 0.6 mg/dL). RAA
repair included bypass (67%), aneurysmorrhaphy (15%), or a combination (17%). One planned nephrectomy (1%) was
performed for un-reconstructable disease. Branch RA reconstruction in 78% used ex vivo cold perfusion in 50%, in situ
cold perfusion in 29%, and warm in situ repair in 21%. Of 9 bilateral RAA repairs, 7 (78%) were staged and 2 (22%) were
simultaneous. Combined aortic reconstruction was required in 6 (10%) patients. Perioperative death occurred in 1 patient
(1.6%), and significant morbidity was observed in 8 patients (12%). Hypertension was considered improved in 54%, cured
in 21%, and unchanged in 25% at mean follow-up of 48 months (range, 1-156 months). Among patients with renal
insufficiency, renal function was improved in 3 (60%), unchanged in 1 (20%), and declined in 1 (20%). Follow-up patency
(mean, 33 months; range, 1-118 months) was determined for 64 (91%) RA reconstructions. Product-limit estimate of
primary patency at 48 months was 96%. Product-limit estimate of survival was 91% at 120 months.
Conclusion: RAAs were repaired with low morbidity and mortality. Complex branch RAA repair using cold perfusion
preservation and ex vivo techniques resulted in no unplanned nephrectomy, with an estimated primary patency of 96% at
48 months. Beneficial blood pressure response was observed in the majority of hypertensive patients. These results
support selective surgical management of RAA. (J Vasc Surg 2004;40:53-60.)The natural history and clinical significance of renal
artery aneurysms (RAAs) are uncertain; hence, the indica-
tions for surgical management remain controversial. Risk of
rupture is often proposed as a rationale for RAA repair;
however, rupture risk appears low in all but the most select
patient groups.1-3 Embolization from RAA may contribute
to renal infarction with hematuria and flank pain, but most
RAAs remain free of these clinical signs and symptoms.4,5
Recently, the contribution of RAA to secondary hyperten-
sion has been emphasized, even though the causative
mechanism(s) is often unclear.4,6-8
Given these uncertainties, surgical management for
RAA must achieve durable anatomic results, with predict-
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describes our institution’s management of RAAs over a
recent 14-year period. The primary objectives of this review
were to: (1) examine the patient selection criteria; (2)
describe the operative strategies of repair; (3) determine the
anatomic result of these strategies; (4) assess the blood
pressure and renal function response after operation.
METHODS
Patient information. Patients who received renal ar-
tery (RA) reconstruction from January 1987 through July
2003 were identified from a vascular registry with institu-
tional review board–approved vascular registry. Those who
received repair of RAAs were selected. Excluded from this
report were RAAs treated emergently for rupture, those
receiving initial reconstruction elsewhere, and those asso-
ciated with RA dissection. Review of the hospital records,
imaging studies, and clinic records was performed for all
patients. Patient risk factors and comorbidity were re-
corded. Measured clinical outcomes included blood pres-
sure, number of antihypertensive medications, and serum
creatinine (SCr). Anatomic assessment of repair was evalu-
ated by renal duplex sonography or angiography. Data
obtained at the initial preoperative clinic visit and the latest
postoperative clinical and anatomic follow-up was used in53
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low-up and a National Death Index search.
Hypertension response to operation was determined by
blood pressure and antihypertensive medication require-
ments at last follow-up (at least 8 weeks after operation).9
Renal function response was determined from changes in
serum creatinine (SCr) examined at last follow-up (at least
3 weeks after surgery).10
Renal duplex sonography. Renal duplex sonography
(RDS) was performed by registered vascular technologists
with extensive experience in the technique. Patients were
studied at 3 months after repair and then annually. The
renal artery peak systolic velocity (RA-PSV; m/s) was esti-
mated from spectral analysis of the Doppler-shifted signal.
RDS was considered negative or positive for renal artery
stenosis (RAS), or inadequate for interpretation based on
the following criteria: (1) RDS was negative for RAS when
the RA-PSV from aortic origin to renal parenchyma was
1.8 m/s; (2) RDS was positive for RVD when the RA-
PSV exceeded 1.8 m/s in any segment of the renal artery
(ie, 60% renal artery diameter-reducing stenosis) or lack
of a Doppler-shifted signal from an imaged renal artery (ie,
renal artery occlusion); or (3) RDS was technically inade-
quate for interpretation when renal artery Doppler signals
were not obtained from the entire renal artery.11
Statistical method. Data were examined for all pa-
tients undergoing elective repair of RAA. Univariate tests of
association for categorical data were performed using 2
tests. Continuous factors were compared by using two-
sample t tests. Censored primary outcomes, durability of
repair, and patient survival were examined by using life-
table methods. Graphical depiction of repair patency and
patient survival were constructed by using product-limit
estimates. Secondary outcomes examined were blood pres-
sure and renal response. Multivariate associations between
secondary outcomes and preoperative parameters were ex-
amined by using logistic regression models.
RESULTS
Clinical presentation. Patient demographic and co-
morbid characteristics are depicted in Table I. Sixty-two
patients (42 women, 20 men; mean age, 46 18 years) had
84 RAAs. Comorbidities included diabetes (15%), cardiac
arrhythmia (13%), chronic obstructive pulmonary disease
(12%), cerebrovascular disease (10%), dyslipidemia (9%),
coronary artery disease (8%), and congestive heart failure
(4%). Hypertension was present in 89% of patients (mean
blood pressure, 171  34/94  19 mm Hg; mean medi-
cations, 2.2  1.2 drugs). Five patients (8%) had renal
insufficiency with a mean SCr of 1.9 mg/dL (range, 1.6-
2.9 mg/dL).
Indications for RAA reconstruction are depicted in
Table II. Women of reproductive age and children ac-
counted for 39% of patients. The indication for RAA repair
in women of childbearing age was the presence of an RAA.
In addition, these patients frequently had associated hyper-
tension (75%) or symptoms (6%). Children received RAA
repair on the basis of the presence of RAA, but each hadassociated hypertension. Among the older adults 84% had
severe hypertension, 11% had renal embolization, and 3%
had symptomatic RAA. One adult woman with a clinically
silent 5-cm RAA underwent repair on the basis of size
alone.
Renal artery anatomy and treatment. Characteris-
tics of repaired RAA are summarized in Table III. Athero-
sclerosis, fibromuscular dysplasia, or arteritis coexisted in
54%, 35%, and 7% of RAAs, respectively. The mean RAA
diameter was 2.6 cm (range, 1.3-5.5 cm). Overall, 72 RAAs
were surgically treated. Seventy-one RAAs were recon-
structed, and 1 planned nephrectomy was performed for
unreconstructable disease. Reconstruction of RAAs in-
volved the right RA in 56% and the left RA in 44%. Bilateral
Table I. Demographics and comorbidity
Patients (n  62) %
Age (y) 46  18*
Gender
Men 32
Women 68
Race
Caucasian 81
African-American 11
Other 8
Comorbid condition
Hypertension 89
Diabetes 15
Cardiac arrythmia 13
COPD 12
Cerebrovascular disease 10
Dyslipidemia 9
Coronary disease 8
Renal Insufficiency 8
Congestive heart failure 4
COPD, Chronic obstructive pulmonary disease.
*Age expressed as mean  SD.
Table II. Indications for RAA repair
Indication Pts (%)
Women of childbearing age* (mean age, 34  12 y) 16 (26)
Presence of RAA 16
Hypertension 12
Asymptomatic 3
Symptomatic 1
Children (mean age, 15  5 y; 6 boys, 2 girls) 8 (13)
Presence of RAA 8
Hypertension 7
Hypertension  embolization 1
Older adults† (mean age, 57  12 y) 38 (61)
Hypertension 30
Embolism 4
Hypertension  large size 2
Size alone 1
Symptomatic 1
Ages expressed as mean  SD.
RAA, Renal artery aneurysm.
*Women 12-45 years old.
†Men 21 years old and women 45 years old.
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ceived bilateral repair by a staged approach in 7 cases and
simultaneous repair in 2 cases. Fifty-six (78%) repaired
RAAs involved branch RA reconstructions. Focal renal
artery stenosis was identified in combination with 16 (22%)
RAAs.
The method of RAA repair is summarized in Table IV.
Bypass techniques were used in 60 (83%) RAAs, including
47 aortorenal and 1 hepatorenal bypass. Bypass conduit
included saphenous vein (75%), prosthetic material (17%),
and hypogastric artery (6%). In one case (2%), prosthetic
material was used to revise a major B-scan defect within a
saphenous vein graft defined by duplex sonography. Aneu-
rysmorrhaphy alone was performed in 11 (15%) RAA re-
constructions and included vein patch angioplasty (6
cases), and suture exclusion procedures (5 cases). Aneu-
rysmorrhaphy was used as an adjunct to RA bypass in 12
(17%) RAA repairs.
Fifty-six (78%) RAAs required branch RA repair. Renal
preservation during branch RA repair included ex vivo cold
perfusion in 28 (50%) cases. During the latter half of the
Table III. Characteristics of repaired RAAs
Characteristic
RAA (%)
(n  72)
Size (cm) 2.6 (1.3-5.5)*
Right 40 (56)
Left 32 (44)
Bilateral 9 (15)†
Staged 7 (78)†
Simultaneous 2 (22)†
Multiple 8 (11)
Branch 56 (78)
Associated Conditions
Fibromuscular dysplasia 39 (54)
Atherosclerosis 25 (35)
Arteritis 5 (7)
RAA, Renal artery aneurysm.
*Expressed as mean (range) diameter.
†Expressed as patients (%).
Table IV. Surgical treatment of RAAs
Technique (n  72) n (%)
Aneurysmorrhaphy 11 (15)
Exclusion 5 (7)
Patch angioplasty 6 (8)
Bypass 48 (67)
Aortorenal 47 (59)
Hepatorenal 1 (1)
Bypass  aneurysmorrhaphy 12 (17)
Nephrectomy 1 (1)
Branch repair (n  56 [78%])
Cold perfusion 44 (79)*
Ex.vivo 28 (50)*
In situ 16 (29)*
Warm in situ 12 (21)*
RAA, Renal artery aneurysm.
*Percentage of branch repairs.series, in situ cold perfusion was used in another 16 (29%)
RAA repairs. In this later technique, the renal vein was not
divided, but rather was occluded and venous effluent
vented. Warm in situ repair was performed in 12 (21%)
cases of branch RA repair.
Twelve RAAs contralateral to unilateral RAA repair
were not reconstructed due to small size (10 cases), non-
functioning kidney (1 case), or repair elsewhere (1 case).
Combined aortic reconstructions were performed in 6
(10%) patients and included 1 patch aortoplasty for mid-
aortic syndrome, 1 aortofemoral bypass graft for aortic
occlusion, and 4 abdominal aortic aneurysm repairs.
Early in this series, assessment of RA reconstruction
included postoperative angiography performed prior to
hospital discharge. Of the 17 RA reconstructions evaluated
with angiography, 1 (6%) demonstrated significant residual
RA stenosis that required operative revision prior to dis-
charge. After 1992, assessment was made by intraoperative
duplex sonography. Intraoperative completion duplex
sonography was performed as a completion study in 51
(91%) RAA repairs. Major B-scan defects were noted in 4
reconstructions (8%) and each was immediately revised.
Early outcomes. One patient (1.6%), a 66-year-old
patient with advanced cirrhosis and a symptomatic RAA,
died in the perioperative period. Perioperative death was
due to multisystem organ failure resulting from postoper-
ative hemorrhage.
Eight patients (12%) experienced perioperative compli-
cations extending hospitalization. These included 2 wound
infections and 1 case each of perforated peptic ulcer, ileus,
transient renal insufficiency, chylous ascites, and sacral de-
cubitus. A woman who had undergone nephrectomy for a
ruptured RAA during a prior pregnancy presented gravid
with a symptomatic contralateral RAA. Renal artery recon-
struction was successful; however, the fetus spontaneously
aborted in the perioperative period.
Late outcomes. Clinical follow-up was complete for
all patients (mean, 47 months; range, 1-156 months).
Overall, hypertension was considered cured in 21%, im-
proved in 54%, and unchanged in 25% of patients. Patients
with hypertension demonstrated decreased systolic (preop-
erative 171  34 mm Hg vs postoperative 134  20 mm
Hg; P .0001), diastolic (preoperative 94 19 mm Hg vs
postoperative 82  10 mm Hg; P  .0003), and mean
arterial (preoperative 115 33 mm Hg vs postoperative 90
 27 mm Hg; P .0001) blood pressures. Blood pressure
control was maintained with fewer anti-hypertensive med-
ications after repair (2.2 vs1.5; P  .02). Higher pre-
operative diastolic blood pressure (odds ratio, 10.7; 95%
confidence interval, 1.87-61.2), and increased number of
blood pressure medications (odds ratio, 2.8; 95% confi-
dence interval, 1.1-7.3) were associated with beneficial
blood pressure response. Among individuals with bilateral
RAAs there was no significant difference in beneficial blood
pressure response based on unilateral or bilateral repair
(78% vs 56%). There was no difference in blood pressure
response between ex vivo or in situ RAA repair (76% vs
86%). Of the 5 patients (8%) with preoperative renal insuf-
arter
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in 1. One patient with a horseshoe kidney and baseline SCr
of 2.9 mg/dL received warm in situ repair of an RAA and
combined aortic reconstruction. Despite confirmation of
RA patency by duplex sonography, this patient progressed
to end-stage renal disease and dialysis dependence 6
months after surgery. Eleven contralateral RAAs in patients
with bilateral RAAs were not repaired because of small size
and lack of clinical manifestations. Each unrepaired RAA
was 2 cm in diameter. On mean follow-up of 34 months
(range, 3-75 months), no RAA ruptured, increased in size,
or presented with symptoms.
Follow-up evaluation was performed on 64 (91%) RAA
reconstructions (mean, 33 months; range, 1-118 months).
Two bypass grafts in women aged 65 and 76 years demon-
strated hemodynamically significant stenoses at 2 and 5
years after surgery. In the absence of hypertension or renal
insufficiency, revision was not attempted in either case.
Product-limit estimate of primary patency was 96% at 48
months (Fig 1). Estimated patency did not differ for ex vivo
and in situ RAA repair (93% vs. 100%).
Fig 1. Product limit estimate of renalFollow-up survival data was complete for all patients.
Product-limit estimate of survival was 91% at 120 months
(Fig 2).
DISCUSSION
This retrospective review describes surgical repair of 72
RAAs in 62 consecutive patients treated over a recent
14-year period. With the operative strategies employed,
mortality (1.6%) and morbidity (12%) were low and bene-
ficial blood pressure response (75%) was high, with no
unplanned nephrectomy despite branch RA repair in 78%
of cases. Estimated primary patency was 96% at 48 months.
Only 1 patient with severe preoperative renal insufficiency
demonstrated decline in kidney function over time. Surgi-
cal management of RAA was supported by these results in
view of the 91% 10-year survival estimated among this
patient cohort.
Patient selection criteria for RAA repair have com-
monly related patient demographics and anatomic features
of the aneurysm to risk of rupture.12-14 Young women with
anticipated pregnancy have been considered at high risk for
y patency (SE 10% at each interval).
llowi
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mother and fetus.6,8,15,16 Of commonly suggested selec-
tion criteria for RAA repair, this appears to be the most
widely accepted and was employed in 16 (26%) patients in
this series. Notably, a pregnant patient in her second tri-
mester was treated for a symptomatic RA aneurysm after
treatment for a contralateral RAA rupture during a previous
pregnancy.
Some authors have cited absolute size as a sole criterion
for RAA repair.5,17 Most often, a 2-cm size has been
considered a threshold for repair, although aneurysms less
than 2.0 cm have ruptured.6,13 Fusiform shape and calcifi-
cation have been suggested as protective against rupture;
however, several series have demonstrated no correlation
between these characteristics and rupture risk.1,4,18-20 By
contrast, patients reported in this series were selected for
surgical therapy independent of aneurysm shape or calcifi-
cation. Moreover, absolute aneurysm size was not used as a
sole indication for intervention, but was considered in
context of the patient’s age, associated symptoms, and the
presence of severe hypertension. RAAs less than 2.0 cm in
Fig 2. Product limit estimate of survival fosize among adults without clinical symptoms or severe
hypertension were not recommended for repair. This rec-
ommendation included 11 patients with bilateral RAAs
who underwent only unilateral repair. In these patients, the
contralateral RAA was less than 2.0 cm in size and hyper-
tension was cured or improved after surgical management.
In each instance, the unrepaired RAA has remained stable
without symptoms on mean follow-up of 34 months. Five
RAAs less than 2.0 cm in size were repaired among adults.
In each instance, the patient was hypertensive on blood
pressure medication.
Otherwise, patients with RAA associated with emboli-
zation or severe hypertension received repair. Among these
selection criteria, the relationship between RAA and hyper-
tension has only recently been emphasized.1,6,8,21-25 A
number of possible contributions to a renin-mediated hy-
pertension have been postulated.4,6-8,26 These have in-
cluded coexistent renal artery stenosis, embolization of the
distal renal parenchyma, compression or kinking of associ-
ated RA branches, and turbulent blood flow within the
RAA resulting in decreased distal RA perfusion pressure.
ng RAA repair (SE 10% at each interval).
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firmed or refuted in this series. Eighty-nine percent of
patients demonstrated hypertension, but only 22% demon-
strated a focal renal artery stenosis and 8% had evidence of
distal embolization. Despite this, 75% of hypertensive pa-
tients experienced beneficial blood pressure response after
RAA repair, including 21% who were normotensive off all
medications.
Given the complicated RA anatomy frequently ob-
served in this patient group, operative strategies employed
in this patient group deserve comment. Surgical exposure
was most commonly obtained with a wide subcostal inci-
sion via a transperitoneal route. With a roll beneath the
ipsilateral flank and the patient in a flexed position, a
subcostal incision parallel to the costal margin was most
commonly used. RAA repair requiring bilateral branch
renal artery reconstruction was most commonly staged (7
of 9 cases). The second repair was performed 3 to 6 months
after the first. When greater than 40 minutes warm renal
ischemia was anticipated for RA exposure or reconstruc-
tion, cold perfusion preservation and topical ice cooling
was employed (44 cases). In addition, direct aortorenal
reconstruction was employed in preference to indirect or
splanchnorenal reconstruction (47 of 48 cases). Saphenous
vein (75%) was the preferred conduit in adults, while arte-
rial autograft (hypogastric artery) was preferred for chil-
dren. Whenever possible, the operative procedure was lim-
ited to RA repair—RAA repair was combined with aortic
reconstruction only when strong clinical indications ex-
isted. Regardless of the method of repair, reconstructions
after 1992 were evaluated with intraoperative renal duplex
sonography. Major B-scan defects were observed in 8% of
cases and these were revised at the initial operation.
Two cold perfusion preservation techniques were used
in branch renal artery reconstructions and these deserve
special comment. In ex vivo repairs, Gerota’s fascia was
opened, and the kidney and renal pedicle were freed from
surrounding structures. The ureter was mobilized to the
pelvic brim and periureteric collaterals were controlled with
an elastic sling, with the ureter left intact. Prior to division
of the renal artery and vein, the patient was given intrave-
nous heparin and mannitol. After division of the RA, a
partial occluding clamp was placed at the junction of the
renal vein and vena cava, and the vein divided with a cuff of
cava. The kidney was elevated on a plastic barrier, placed in
ice slush, and perfused with chilled Travenol solution
(Travenal Labs, Inc, Deerfield, Ill; modified with the addi-
tion of 70-gm dextrose and 2000 units unfractionated
heparin to each liter) until the venous effluent was clear. As
each distal anastomosis was completed, the kidney was
perfused with additional cold preservation solution. After
completion of the distal RA reconstruction, the kidney was
returned to the renal fossa and the renal vein anastomosis
was completed first, followed by the proximal aortorenal
anastomosis. Alternatively, when adequate exposure could
be obtained without division of the renal vein, an in situ
repair was performed with cold perfusion. In this tech-
nique, exposure and perfusion was identical; however, therenal vein was occluded and left intact, and a small venot-
omy provided a vent for the preservation solution. The
value of this latter technique was inferred from failure in 3
of 100 ex vivo renal artery repairs performed for occlusive
disease during this same period. In 2 of these 3 cases, the
failure was due to complications at the venous anastomosis.
The utility of these cold perfusion preservation tech-
niques was suggested by the immediate and follow-up
results of surgical management. Branch exposure was re-
quired in all RAA repairs and branch reconstruction was
performed in 78% of cases. Despite this complex surgical
anatomy, no unplanned nephrectomy was performed at the
initial operation or in follow-up. Among patients with
either angiography or renal duplex assessment, estimated
primary patency was 96% at 48 months. Compared with
surgical results from other contemporary series, the absence
of unplanned nephrectomy and low rate of failed repair on
follow-up support these revascularization techniques in this
long-lived patient population.
Endovascular treatments for RAA have recently been
described as alternatives to open surgical repair.27-34 These
reports have described two general approaches—transcath-
eter embolization and endovascular grafting. In one of the
largest experiences using embolization, Klein et al27 treated
12 RAAs with microcoils. The treated aneurysms were
located within the main renal artery (2 cases) or the primary
division of the main artery (8 cases), or were intrarenal (2
cases). There were 2 complications of therapy, but each
aneurysm was successfully thrombosed. Two of 4 patients
with hypertension demonstrated improved blood pressure
control at 24- and 28-month follow-up. Endovascular
grafts have also been placed across the origin of the
RAA.29,33-34 Reports have described 3 patients treated
successfully in this fashion, with 12-month patency dem-
onstrated in 2 patients.29,34 Although, collectively, these
data suggest technical success of endovascular treatment for
RAA in experienced hands, whether embolization without
RAA exclusion prevents rupture or whether endovascular
grafting will prove durable is unknown.
In summary, these results support selected surgical
repair of RAAs. Our operative strategies achieved low mor-
tality and morbidity, with a beneficial blood pressure re-
sponse in the majority of hypertensive patients. Cold per-
fusion preservation techniques allowed for complex branch
renal artery repair, with no unplanned nephrectomy and
96% primary patency on long-term follow-up. These results
are particularly important given the long-term survival of
this patient population.
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Available online May 7, 2004.DISCUSSIONDr Thomas C. Naslund (Nashville, Tenn). Dr English and
his coauthors have reported their extensive experience in the
management of renal artery aneurysms over the last 15 years
with a variety of surgical techniques but with consistent excel-
lent results. This report provides information in terms of out-
come from renal artery aneurysm repair, which is difficult to
appreciate without single-center reviews such as this. While
indications for the management of renal aneurysms have long
been a part of the vascular literature, there are a few reports
indicating the outcome one expects from renal aneurysm oper-
ations.
Dr English, your data were collected from clinical follow-up
by censoring patients at their last clinical visit. I am curious as to
whether or not this might have affected some of your data, in
particular data related to your blood pressure benefit. Do you have
an understanding of clinically relevant issues that might improve
blood pressure in your late follow-up patients, other than opera-
tion? For example, did they lose weight? Were they more compli-
ant with medications than some postoperative patients are, or were
they on a better combination of medications than they were
preoperatively?Regarding your duplex follow-up information regarding pa-
tency, you have excellent follow-up of more than 90% of your
patients being followed with duplex over the long term, yet you
identified a paucity of anatomic problems associated with your
grafts. In fact, none required any revisions. Do you continue to use
duplex in follow-up, and, if so, what criteria do you seek to indicate
need for reinterventions?
Finally, on a technical note, do you perform all of your ex vivo
reconstructions with the organ replaced in the orthotopic position
as you showed in your video, or do you on occasion move the
organ more caudally where the venous anastomosis can be techni-
cally more easily accomplished?
Dr William English. Thank you, Dr Naslund. I’ll address
your questions in reverse order.
With respect to kidney placement, each of these repairs was
performed in the orthotopic position. Particularly among young
women and children, this position avoids the atherosclerosis that
can be expected in many of these patients over the long term by
placing the kidney at the iliac level, for instance.
With respect to the duplex sonography, each of our patients
received follow-up renal duplex studies, generally at 6-month
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intervals. Our indications for intervention based on duplex evi-
dence of renal artery stenosis were the presence of clinical manifes-
tations, severe hypertension, or diminished renal excretory func-
tion. Neither of the cases that demonstrated renal artery stenoses
had associated clinical manifestations and were not revised.
With respect to blood pressure response, that’s a very good
question. We looked at blood pressure at initial and latest follow-
up, at least 8 weeks following surgery. There was no significant
difference in these measures, so it seemed that the blood pressure
response was maintained over time. However, as you note, im-
provements in blood pressure medications may account for some
of the blood pressure control. Blood pressure medications used
later in the series were better in general than those used early on. It
seems that beneficial blood pressure response following renal ar-
tery aneurysm repair was durable, consistent with other contem-
porary reports.Dr James Seeger (Gainesville, Fla). You have shown a signif-
icant change in the blood pressure, but it is a clinically significant
change? Did you really change these people’s risk by the fact that
they take 1&rtf-symbol-50; pills as opposed to 2 pills a day. I mean,
is their blood pressure control better or are they just taking
different medications to achieve that same control?
Dr English. These individuals had a decreased number of
medications, a significant number of medications, and decreased
blood pressure from the 170 range, so they were hypertensive,
down to the 130 systolic, and from 105 to less than 90 diastolic.
The question then becomes, what impact does that have on
longevity, and that has been a subject of debate and is ongoing. I
don’t know the answer at this point, but it appears to be durable,
with decreased cost as far as medications go. That was another
point, that the cost of medications over a lifetime in these children
or young women—3 or 4 medications required—is astronomical
with some of the newer agents.
